1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow David Binion, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). Bezlotoxumab - Inflammatory Bowel Diseases, Ulcerative Colitis | Phase 4 | Terminated | David Binion, MD | 19 | 2021-10-14 | 2025-06-05 |
Clostridium Infections (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Inflammatory Bowel Diseases (1)
bezlotoxumab (1)
United States (1)